13 hours ago
Ord Minnett Remains a Buy on Regis Healthcare Ltd. (REG)
Ord Minnett analyst Tom Godfrey maintained a Buy rating on Regis Healthcare Ltd. (REG – Research Report) today and set a price target of A$8.25. The company's shares opened today at A$7.36.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Godfrey is a 3-star analyst with an average return of 7.9% and a 36.73% success rate. Godfrey covers the Healthcare sector, focusing on stocks such as Monash IVF Group Ltd, Sigma Healthcare Ltd, and EBOS Group Limited.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Regis Healthcare Ltd. with a A$8.93 average price target, representing a 21.33% upside. In a report released on June 5, Jefferies also maintained a Buy rating on the stock with a A$8.80 price target.
